IRIS Accounts Production v24.3.0.553 09378094 Board of Directors 1.5.23 30.4.24 30.4.24 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh093780942023-04-30093780942024-04-30093780942023-05-012024-04-30093780942022-04-30093780942022-05-012023-04-30093780942023-04-3009378094ns15:EnglandWales2023-05-012024-04-3009378094ns14:PoundSterling2023-05-012024-04-3009378094ns10:Director12023-05-012024-04-3009378094ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3009378094ns10:SmallEntities2023-05-012024-04-3009378094ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3009378094ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3009378094ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3009378094ns10:FullAccounts2023-05-012024-04-3009378094ns10:Director22023-05-012024-04-3009378094ns10:RegisteredOffice2023-05-012024-04-3009378094ns5:CurrentFinancialInstruments2024-04-3009378094ns5:CurrentFinancialInstruments2023-04-3009378094ns5:ShareCapital2024-04-3009378094ns5:ShareCapital2023-04-3009378094ns5:RetainedEarningsAccumulatedLosses2024-04-3009378094ns5:RetainedEarningsAccumulatedLosses2023-04-3009378094ns5:UnlistedNon-exchangeTradedns5:CostValuation2023-04-3009378094ns5:UnlistedNon-exchangeTraded2024-04-3009378094ns5:UnlistedNon-exchangeTraded2023-04-30
REGISTERED NUMBER: 09378094 (England and Wales)












NORTON MEDICAL LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2024






NORTON MEDICAL LIMITED (REGISTERED NUMBER: 09378094)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


NORTON MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 APRIL 2024







DIRECTORS: Mr N N L Butcher
Mrs M I E Butcher





REGISTERED OFFICE: Highland House
Mayflower Close
Chandlers Ford
Eastleigh
Hampshire
SO53 4AR





REGISTERED NUMBER: 09378094 (England and Wales)

NORTON MEDICAL LIMITED (REGISTERED NUMBER: 09378094)

BALANCE SHEET
30 APRIL 2024

2024 2023
Notes £ £
FIXED ASSETS
Investments 4 678,896 678,896

CURRENT ASSETS
Cash at bank 441 118

CREDITORS
Amounts falling due within one year 5 (1,700 ) (83,451 )
NET CURRENT LIABILITIES (1,259 ) (83,333 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

677,637

595,563

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 677,636 595,562
SHAREHOLDERS' FUNDS 677,637 595,563

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

NORTON MEDICAL LIMITED (REGISTERED NUMBER: 09378094)

BALANCE SHEET - continued
30 APRIL 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 October 2024 and were signed on its behalf by:





Mr N N L Butcher - Director


NORTON MEDICAL LIMITED (REGISTERED NUMBER: 09378094)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024


1. STATUTORY INFORMATION

Norton Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with FRS 102 "The Financial Reporting Standards applicable in the UK and Republic of Ireland" ("FRS 102") and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies' regime.

The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £1.

The financial statements have been prepared under the historical cost convention, modified to include certain financial instruments at fair value. The principal accounting policies adopted are set out below.

The company has taken advantage of the small companies' exemption not to prepare consolidated accounts.

Fixed asset Investments
Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in the income statement.

Financial assets
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial assets are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Basic financial assets, which include trade and other receivables and cash and bank balances are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method, unless the arrangement constitutes a financial transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Financial liabilities
Basic financial liabilities, which include trade and other payables, are initially measured at transaction price and subsequently measured at amortised cost, unless the arrangement constitutes a financing transaction where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

Equity instruments
Equity instruments issued by the company are recorded at the fair value of the proceeds received net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

NORTON MEDICAL LIMITED (REGISTERED NUMBER: 09378094)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024


3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. FIXED ASSET INVESTMENTS
Unlisted
investments
£
COST
At 1 May 2023
and 30 April 2024 678,896
NET BOOK VALUE
At 30 April 2024 678,896
At 30 April 2023 678,896

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Other creditors 1,700 83,451